Former power producer SG Power Limited has formally moved into the healthcare industry, with plans to build expertise in pharmaceutical-related businesses. The Securities and Exchange Commission of Pakistan (SECP) has registered “Pharmaceutical Allied” as the company’s new principal line of business.

The listed company informed the Pakistan Stock Exchange (PSX) about this development through a formal notice. Following this strategic shift, the company will now focus on manufacturing and trading medical devices, hospital supplies, and pharmaceutical products.

According to the notice, after approval of a special resolution in the Extraordinary General Meeting (EOGM) held on May 13, 2026, and completion of necessary regulatory filings with the SECP, the company’s principal business has officially been changed from power generation to Pharmaceutical Allied (healthcare sector).

Under its revised scope of operations, the company is now authorized to engage in the import, export, manufacturing, distribution, marketing, sales, rental, installation, maintenance, and after-sales services of medical equipment, hospital supplies, and related healthcare products. It will also be able to manufacture and sell pharmaceutical and related products.

The company stated that this transition marks an important milestone in its strategic direction and provides a regulatory framework for exploring new opportunities in Pakistan’s healthcare and pharmaceutical sectors.

It is worth noting that SG Power Limited was incorporated in Pakistan on February 10, 1994, under the Companies Ordinance 1984. Its original business was electricity generation, supplying power to its associated company, SG Allied Businesses Limited. The company is classified as an Independent Power Producer (IPP).

In May 2026, SG Power Limited also announced plans to raise approximately PKR 535 million through a rights issue. The main purpose of this fundraising was to invest in the healthcare sector and related businesses, aiming to expand and strengthen operations and support future growth initiatives. The company believes this move will diversify and stabilize its revenue streams.